循證醫(yī)學(xué)詞匯大全
循證醫(yī)學(xué)(英語:Evidence-based medicine,縮寫為EBM),意為“遵循證據(jù)的醫(yī)學(xué)”,又稱實(shí)證醫(yī)學(xué),港臺(tái)地區(qū)也譯為證據(jù)醫(yī)學(xué)。接下來小編為大家整理了循證醫(yī)學(xué)詞匯大全,希望對(duì)你有幫助哦!
A
安全性 Safety
B
半隨機(jī)對(duì)照試驗(yàn) quasi- randomized control trial,qRCT
背景問題 background questions
比值比 odds ratio,OR
標(biāo)準(zhǔn)化均數(shù)差 standardized mean difference, SMD
病例報(bào)告 case report
病例分析 case analysis
病人預(yù)期事件發(fā)生率 patient's expected event rate, PEER
補(bǔ)充替代醫(yī)學(xué) complementary and alternative medicine, CAM
不良事件 adverse event
不確定性 uncertainty
C
Cochrane圖書館 Cochrane Library, CL
Cochrane系統(tǒng)評(píng)價(jià) Cochrane systematic review, CSR
Cochrane協(xié)作網(wǎng) Cochrane Collaboration, CC
Cox比例風(fēng)險(xiǎn)模型 Cox' proportional hazard model
參考試驗(yàn)偏倚 References test bias
腸激惹綜合征 irritable bowel syndrome,IRB
測(cè)量變異 measurement variation
成本-效果 cost-effectiveness
成本-效果分析 cost-effectiveness analysis
成本-效益分析 cost-benefit analysis
成本-效用分析 cost-utility analysis
成本最小化分析(最小成本分析)cost-minimization analysis
重復(fù)發(fā)表偏倚 Multiple publication bias
傳統(tǒng)醫(yī)學(xué) Traditional Medicine,TM
D
D—L法 DerSimonian & Laird method
發(fā)生一例不良反應(yīng)所需治療的病例數(shù)
the number needed to harm one more patients from the therapy,NNH
對(duì)抗療法 allopathic medicine,AM
對(duì)照組中某事件的發(fā)生率 control event rate,CER
多重發(fā)表偏倚 multiple publication bias (刪除此詞)
E
二次研究 secondary studies
二次研究證據(jù) secondary research evidence
F
發(fā)表偏倚 publication bias
防止1例不良事件發(fā)生或得到1例有利結(jié)果需要治療的病例數(shù)
number needed to treat,NNT
非隨機(jī)同期對(duì)照試驗(yàn) non-randomized concurrent control trial
分層隨機(jī)化 stratified randomization
分類變量 categorical variable
風(fēng)險(xiǎn)(危險(xiǎn)度) risk
G
干擾 co-intervention
工作偏倚 Workup bias
固定效應(yīng)模型 fixed effect model
國(guó)際臨床流行病學(xué)網(wǎng) International Clinical Epidemiology Network, INCLEN
H
灰色文獻(xiàn) grey literature
后效評(píng)價(jià) reevaluation
獲益 benefit
J
機(jī)會(huì)結(jié) chance node
疾病譜偏倚 Spectrum bias
技術(shù)特性 Technical properties
加權(quán)均數(shù)差 weighted mean difference, WMD
假陽性率(誤診率) false positive rate
假陰性率(漏診率) false negative rate
簡(jiǎn)單隨機(jī)化 simple randomization
檢索策略 search strategy
交叉對(duì)照研究(交叉設(shè)計(jì)) crossover design
經(jīng)濟(jì)學(xué)分析 economic analysis
經(jīng)濟(jì)學(xué)特性 Economic attributes or impacts
經(jīng)驗(yàn)醫(yī)學(xué) empirical medicine
精確性 precision
決策結(jié) decision node
決策樹分析 decision tree analysis
絕對(duì)獲益增加率 absolute benefit increase, ABI
絕對(duì)危險(xiǎn)度降低率 absolute risk reduction, ARR
絕對(duì)危險(xiǎn)度增加率 absolute risk increase, ARI
K
可重復(fù)性 repeatability,reproducibility
可靠性(信度) reliability
可信區(qū)間 confidence interval ,CI
可信限 confidence limit ,CL
L
Logistic回歸模型 Logistic regression model
歷史性對(duì)照研究 historical control trial
利弊比 likelihood of being helped vs harmed, LHH
連續(xù)性變量 continuous variable
臨床對(duì)照試驗(yàn) controlled clinical trial, CCT
臨床結(jié)局 clinical outcome
臨床經(jīng)濟(jì)學(xué) clinical economics
臨床決策分析 clinical decision analysis
臨床流行病學(xué) clinical epidemiology, CE
臨床實(shí)踐指南 clinical practice guidelines, CPG
臨床試驗(yàn) clinical trial
臨床研究證據(jù) clinical research evidence
臨床證據(jù) clinical evidence
臨床證據(jù)手冊(cè) handbook of clinical evidence
零點(diǎn) Zero time
靈活性 flexibility
臨界點(diǎn) Cut off points
漏斗圖 funnel plots
率差(或危險(xiǎn)差) rate difference,risk difference,RD
M
Meta-分析 Meta-analysis
敏感度 sensitivity
敏感性分析 sensitivity analysis
墨克手冊(cè) Merck manual
N
腦卒中病房 Stroke Unit
內(nèi)在真實(shí)性 internal validity
P
偏倚 bias
Q
起始隊(duì)列 inception cohort
前-后對(duì)照研究 before-after study
前景問題 foreground questions
區(qū)組隨機(jī)化 block randomization
S
散點(diǎn)圖 scatter plots
森林圖 forest plots
傷殘調(diào)整壽命年 disability adjusted life year,DALY
生存曲線 survival curves
生存時(shí)間 survival time
生存質(zhì)量(生活質(zhì)量) quality of life
世界衛(wèi)生組織 World Health Organization, WHO
失安全數(shù) fail-Safe Number
試驗(yàn)組某事件發(fā)生率 experimental event rate,EER
似然比 likelihood Ratio, LR
適用性 applicability
受試者工作特征曲線(ROC曲線)receiver operator characteristic curve
隨機(jī)對(duì)照臨床試驗(yàn) randomized clinical trials, RCT
隨機(jī)對(duì)照試驗(yàn) randomized control trial, RCT
隨機(jī)化隱藏 randomization concealment
隨機(jī)效應(yīng)模型 random effect model
T
特異度 specificity
同行評(píng)價(jià) colleague evaluation
統(tǒng)計(jì)效能(把握度) power
同質(zhì)性檢驗(yàn) tests for homogeneity
W
外在真實(shí)性 external validity
完成治療分析 per protocol,PP
腕管綜合征 carpal tunnel syndrome, CTS
衛(wèi)生技術(shù) health technology
衛(wèi)生技術(shù)評(píng)估 health technology assessment, HTA
X
系統(tǒng)評(píng)價(jià) systematic review, SR
相對(duì)獲益增加率 relative benefit increase, RBI
相對(duì)危險(xiǎn)度 relative risk,RR
相對(duì)危險(xiǎn)度降低率 relative risk reduction, RRR
相對(duì)危險(xiǎn)度增加率 relative risk increase, RRI
效果 effectiveness
效力 efficacy
效應(yīng)尺度 effect magnitude
效應(yīng)量 effect size
序貫試驗(yàn) sequential trial
選擇性偏倚 selection bias
循證兒科學(xué) evidence-based pediatrics
循證婦產(chǎn)科學(xué) evidence-based gynecology & obstetrics
循證購(gòu)買 evidence-based purchasing
循證護(hù)理 evidence-based nursing
循證決策 evidence-based decision-making
循證內(nèi)科學(xué) evidence-based internal medicine
循證篩選 evidence-based selection
循證外科學(xué) evidence-based surgery
循證衛(wèi)生保健 evidence-based health care
循證診斷 evidence-based diagnosis
循證醫(yī)學(xué) evidence-based medicine, EBM
Y
亞組分析 subgroup analysis
嚴(yán)格評(píng)價(jià) critical appraisal
驗(yàn)后比 post-test odds
驗(yàn)后概率 post-test probability
驗(yàn)前比 pre-test odds
驗(yàn)前概率 pre-test probability
陽性預(yù)測(cè)值 positive predictive value
原始研究 primary studies
異質(zhì)性檢驗(yàn) tests for heterogeneity
意向治療分析 intention-to-treat, ITT
陰性預(yù)測(cè)值 negative predictive value
引用偏倚 citation bias
尤登指數(shù) Youden's index
語言偏倚 language bias
預(yù)后 prognosis
預(yù)后因素 prognostic factor
預(yù)后指數(shù) prognostic index
原始研究證據(jù) primary research evidence
原始研究證據(jù)來源 primary resources
Z
沾染 contamination
真實(shí)性(效度) validity
診斷參照標(biāo)準(zhǔn) reference standard of diagnosis